1)柿﨑裕彦:甲状腺眼症がよくわかる本 改訂第2版.ブイツーソリューション,名古屋,2011
2)高橋靖弘・他:甲状腺眼症.臨床眼科67:172-180,2013
3)Vannucchi G, et al:Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. J Clin Endocrinol Metab 94:3381-3386, 2009
4)Smith TJ, et al:Graves' disease. N Engl Med J 375:1552-1565, 2016
5)Meyer Zu, et al:The effect of early thyroidectomy on the course of active Graves' orbitopathy(GO):A retrospective case study. Horm Metab Res 48:433-439, 2016
6)Louvet C, et al:Time course of Graves' orbitopathy after total thyroidectiomy and radioiodine therapy for thyroid cancer. Medicine 95:48, 2016
7)Van Dyk HJ, et al:Orbital Graves' disease. A modification of the“NO SPECS”classification. Ophthalmology 88:479-483, 1981
8)Patrinely JR, et al:Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology 96:1038-1047, 1989
9)Mourits MP, et al:Clinical activity score as a guide in the management of patients with Graves'ophthalmopathy. Clin Endocrinol(Oxf) 47:9-14, 1997
10)Dolman PJ, et al:VISA Classification for Graves orbitopathy. Ophthal Plast Reconstr Surg 22:319-324, 2006
11)Metson R, et al:Reduction of diplopia following endoscopic orbital decompression:The orbital sling technique. Laryngoscope 112:1753-1757, 2002